CorMedix (CRMD) Net Margin (2013 - 2025)

CorMedix (CRMD) reported Net Margin of 9.16% for Q4 2025, down 5230.0% on a YoY basis from 0.18% in Q4 2024, and down 108.8% sequentially from 104.08% in Q3 2025.

CorMedix (CRMD) Net Margin (2013 - 2025) Analysis & Trends

CorMedix (CRMD) has 12 years of Net Margin data on file, last reported at 9.16% in Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 5230.0% year-over-year to 9.16%; the trailing twelve-month figure through Dec 2025 stood at 44.68% (up 8589.0% YoY), and the FY2025 full-year result was 44.03%, up 8528.0% from the prior year.
  • Net Margin eased to 9.16% in Q4 2025, from 104.08% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 91671.03% in Q1 2022 to a low of 100538.67% in Q3 2022.
  • A 4-year average of 4498.39% and a median of 52.82% in 2025 frame the typical range for Net Margin.
  • Peak annual rise in Net Margin reached 8351341 bps in 2022, while the deepest fall reached 12311796 bps in 2022.
  • Tracing CRMD's Net Margin over 4 years: stood at 17141.29% in 2021, then plunged by 61 bps to 27637.7% in 2022, then surged by 100 bps to 43.14% in 2024, then sank by 121 bps to 9.16% in 2025.
  • Business Quant data shows CRMD's Net Margin at 9.16% in Q4 2025, 104.08% in Q3 2025, and 55.0% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn -9.16%

Historic Data

Download Data
DateValue
Dec 31, 2025 -9.16%
Sep 30, 2025 104.08%
Jun 30, 2025 55.00%
Mar 31, 2025 52.82%
Dec 31, 2024 43.14%
Sep 30, 2024 -24.28%
Jun 30, 2024 -1,754.86%
Dec 31, 2022 -27,637.70%
Sep 30, 2022 -100,538.67%
Jun 30, 2022 35,759.66%
Mar 31, 2022 91,671.03%
Dec 31, 2021 -17,141.29%
Sep 30, 2021 22,579.29%
Jun 30, 2021 56,159.20%
Mar 31, 2021 8,157.62%
Dec 31, 2020 -68,075.68%
Sep 30, 2020 7,095.25%
Jun 30, 2020 23,110.14%
Mar 31, 2020 7,562.05%
Dec 31, 2019 -21,406.83%